The value of budget impact analyses in evaluating targeted therapies—The case of RSV prophylaxis for preterm infants
Abstract
Authors
Leonard Krilov Deborah Palazzi Ancilla W. Fernandes Robert Klein Parthiv J. Mahadevia
Leonard Krilov Deborah Palazzi Ancilla W. Fernandes Robert Klein Parthiv J. Mahadevia
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now